Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3 β/β-Catenin Signaling Axis

Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research